A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants
Phase 1
Active, not recruiting
- Conditions
- HealthyTherapeutic area: Diseases [C] - Immune System Diseases [C20]
- Registration Number
- CTIS2024-512841-17-00
- Lead Sponsor
- Merck Healthcare KGaA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method